Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Vantage Titan 3T, MRT-3010/A7, M-Power GX

K-Number: K172878 · 2017-11-17

Decision Date2017-11-17
Product CodeLNH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Vantage Titan 3T, MRT-3010/A7, M-Power GX is a medical device manufactured by Toshiba Medical Systems Corporation, Japan. It received FDA 510(k) clearance on 2017-11-17 under approval number K172878. The device is classified under product code LNH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Vantage Titan 3T, MRT-3010/A7, M-Power GX?

Vantage Titan 3T, MRT-3010/A7, M-Power GX is a medical device that received FDA 510(k) clearance on 2017-11-17. It is manufactured by Toshiba Medical Systems Corporation, Japan. The 510(k) number is K172878.

When was Vantage Titan 3T, MRT-3010/A7, M-Power GX approved by the FDA?

Vantage Titan 3T, MRT-3010/A7, M-Power GX received FDA 510(k) clearance on 2017-11-17, under approval number K172878.

What company makes Vantage Titan 3T, MRT-3010/A7, M-Power GX?

Vantage Titan 3T, MRT-3010/A7, M-Power GX is manufactured by Toshiba Medical Systems Corporation, Japan.

What is the FDA product code for Vantage Titan 3T, MRT-3010/A7, M-Power GX?

The FDA product code for Vantage Titan 3T, MRT-3010/A7, M-Power GX is LNH.

Related Clinical Trials

Related Devices (Code: LNH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.